benzonatate
- Product NDC
- 50090-3246
- Requested package NDC
- 50090-3246-0
- 11-digit product format
- 500903246
- Labeler code
- 50090
- Product ID
- 50090-3246_66ba6922-869f-4e97-a95a-6cac59065924
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- benzonatate
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- A-S Medication Solutions
- Application
- ANDA040749
- Marketing category
- ANDA
- Marketing start
- 2017-03-22
- Marketing end
- 0000-00-00
- Substance
- BENZONATATE
- Active strength
- 200 mg/1
- Pharmacologic classes
- Decreased Tracheobronchial Stretch Receptor Activity [PE],Non-narcotic Antitussive [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
NDC auxiliary status#
Explicit status records from FDA unfinished, excluded, and compounder auxiliary files. Absence of a row is not itself a regulatory status. Browse every current auxiliary row, including rows without a usable NDC. · Browse every captured source and parsed snapshot.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded package | package | 50090-3246 | 50090-3246-0 | D | Discontinued by firm | 2026-08-03 |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| benzonatate | BENZONATATE | Bryant Ranch Prepack | a788cb01-6dc3-4f28-aaa0-c23ac058c39a | 2026-05-28 | Warnings, Adverse reactions | 040749 ANDA040749 |
| benzonatate | BENZONATATE | Proficient Rx LP | 9566b9b9-54ef-423c-8ce4-0f1714052158 | 2022-05-01 | Warnings, Adverse reactions | 040749 ANDA040749 |
| benzonatate | BENZONATATE | Proficient Rx LP | 27156dad-64d6-4ea4-a3da-29e8e096fb01 | 2020-01-01 | Warnings, Adverse reactions | 040749 ANDA040749 |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 50090-3246-0 | 2023-02-07 | C162847 | 48780-1 | f386c649-a172-0266-e053-dadaa90a7c1a | Benzonatate Capsules, USP 100 mg, 150 mg and 200 mg |
| 50090-3246-1 | 2023-02-07 | C162847 | 48780-1 | f386c649-a172-0266-e053-dadaa90a7c1a | Benzonatate Capsules, USP 100 mg, 150 mg and 200 mg |
| 50090-3246-2 | 2023-02-07 | C162847 | 48780-1 | f386c649-a172-0266-e053-dadaa90a7c1a | Benzonatate Capsules, USP 100 mg, 150 mg and 200 mg |
| 50090-3246-0 | 2023-01-30 | C162847 | 48780-1 | f386c649-a172-0266-e053-dadaa90a7c1a | Benzonatate Capsules, USP 100 mg, 150 mg and 200 mg |
| 50090-3246-1 | 2023-01-30 | C162847 | 48780-1 | f386c649-a172-0266-e053-dadaa90a7c1a | Benzonatate Capsules, USP 100 mg, 150 mg and 200 mg |
| 50090-3246-2 | 2023-01-30 | C162847 | 48780-1 | f386c649-a172-0266-e053-dadaa90a7c1a | Benzonatate Capsules, USP 100 mg, 150 mg and 200 mg |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 50090-3246-0 | EA - Each | 50090-3246 | 758ad6c9-86c1-4d6d-be22-da06203606ea | 1 | 2019-05-02 |
| 50090-3246-1 | EA - Each | 50090-3246 | 0ba9034e-5498-423e-ac27-3c1394c5b933 | 1 | 2019-05-02 |
| 50090-3246-2 | EA - Each | 50090-3246 | 61735a40-d6cc-4290-8594-5769aa6682b6 | 1 | 2019-05-02 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 50090-3246-0 | 50090324600 | 30 CAPSULE in 1 BOTTLE (50090-3246-0) | 30 capsule | 2017-11-06 | 0000-00-00 | No | No | Current |